Dr. Ai-Ling Lin's lab focuses on understanding how the gut microbiome influences brain health, especially in the context of Alzheimer's disease. The research aims to determine how imbalances in gut bacteria are linked to brain changes and cognitive decline, using advanced imaging techniques and animal models. By exploring dietary interventions and the role of specific biological pathways, the lab hopes to uncover new ways to mitigate the effects of Alzheimer's disease.

Dr. Raghuraman Kannan's lab at the University of Missouri-Columbia focuses on developing innovative nanoparticle technologies to treat drug-resistant non-small cell lung cancer (NSCLC). The team aims to create targeted nanoparticles that can knock down specific proteins responsible for cancer cell survival, overcoming resistance to traditional therapies. Their research combines engineering, biology, and clinical relevance, working towards future therapeutic strategies to improve patient outcomes.